Gene Therapy and Treatment Options for Hemophilia Patients

This chapter explores gene therapy as a potential treatment option for patients with hemophilia, discussing factors that determine candidacy, challenges in administering it to pediatric patients, and its durability and efficacy compared to other treatments. It also mentions non-factor options like Him Libra and a game-changing extended half-life factor eight product called Altevio.